CASH, CASH EQUIVALENTS, AND INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Available-For-Sale Securities Reconciliation

The amortized cost, gross unrealized gains and losses, and fair value of cash, cash equivalents, and marketable securities as of September 30, 2024 and December 31, 2023, are as follows (in millions):

	September 30, 2024
	Cost Basis		Unrealized Gains		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	62	$	—	$	—	$	62	$	62	$	—
Money market funds	767		—		—		767		767		—
Equity securities	8		—		—		8		—		8
Total	$	837	$	—	$	—	$	837	$	829	$	8

	December 31, 2023
	Cost Basis		Unrealized Gains		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	63	$	—	$	—	$	63	$	63	$	—
Money market funds	936		—		—		936		936		—
Corporate debt securities	55		—		(1)		54		—		54
Equity securities	15		—		—		15		—		15
Total	$	1,069	$	—	$	(1)	$	1,068	$	999	$	69

Schedule of Unrealized Loss on Investments

A summary of debt securities with unrealized losses aggregated by period of continuous unrealized loss as of December 31, 2023 is as follows (in millions):

	Less than 12 Months				12 Months or Greater				Total
December 31, 2023	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Corporate debt securities	$	—	$	—	$	54	$	(1)	$	54	$	(1)
Total	$	—	$	—	$	54	$	(1)	$	54	$	(1)

Schedule of Non-Marketable Equity Securities and Equity Method Investments

A summary of non-marketable equity securities and equity method investment balances as of September 30, 2024 and December 31, 2023 are as follows (in millions):

	September 30, 2024		December 31, 2023
Equity method investments	$	21	$	20
Non-marketable equity securities	39		—
Total	$	60	$	20